Swiss Emerald Technology Ventures is investing in Finnish biotech company MetGen that develops industrial enzyme solutions for the pulp & paper industry and non-food biomass transformation into renewable chemicals and fuels.
Emerald joins the Series A financing round which included Sofinnova Partners, Finnish Industry Investment, HST Partners, Finnvera and Cleantech Invest.
― Emerald’s deep domain expertise and global industrial network will be an important pillar in supporting our growth, said Alex Michine, CEO and one of the founders of the company.
Read more about the investment in MetGen’s press release: www.metgen.com
